News and Resources
Dexpramipexole Responsiveness is Increased in Eosinophilic Subjects
Discover this News
Developing Dexpramipexole for the Treatment of Eosinophilic Disorders
Discover this News
Knopp Disclaimer
Knopp’s pipeline consists of investigational drug products that have not been approved by the U.S. Food and Drug Administration. These investigational drug products are undergoing clinical study to verify their safety and effectiveness.